VEGFA and hepatocellular carcinoma: The AFP mRNA/VEGF integrated variable was also tested in the following homogeneous subgroups of HCC patients: BCLC A patients, BCLC B patients and patients treated by resection or ablation procedures with a curative intent (BCLC A–B patients).